C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor?
Vascular relaxation mediated by endothelium-derived hyperpolarizing factor (EDHF) is important for resistance artery function and is underpinned by hyperpolarization of the smooth muscle cells of the blood vessel wall. Debate surrounds the identity of EDHF and its mechanism of action, with the consensus being that there is no universal EDHF. Regional differences in vascular function reflect the complex mechanisms of EDHF. Two primary mechanistic pathways are implicated: (i) myoendothelial gap junctions mediating the spread of endothelial cell hyperpolarization or small signaling molecules (or both) to the smooth muscle; and (ii) diffusible mediators released from the endothelium, including K+ and epoxyeicosatrienoic acids. Here, we discuss the evidence for and against C-type natriuretic peptide (CNP), the latest candidate for a diffusible mediator.
Sandow
Shaun L
SL
Department of Physiology and Pharmacology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia. shaun.sandow@unsw.edu.au
Tare
Marianne
M
D001685:Biological Factors / Q000502:physiology*; D002450:Cell Communication; D004727:Endothelium / Q000502:physiology*; D006801:Humans; D020098:Natriuretic Peptide, C-Type / Q000502:physiology*
D001685:Biological Factors; C067410:endothelium-dependent hyperpolarization factor; D020098:Natriuretic Peptide, C-Type